Experimental study on the mechanism of traditional Chinese medicine Xuanyun-Ⅲ to treat cerebral atherosclerosi

Liu Shiwei,Liu Jing,Lü Xia,Liang Jun,Tian Qinghua,Liu Zhigang,Yin Ling
DOI: https://doi.org/10.3969/j.issn.1005-619X.2013.05.009
2013-01-01
Abstract:Objective To study the therapeutic action and its mechanism of Xuanyun-Ⅲ on cerebral atherosclerosis(AS).Methods Fifty male adult SD rats were randomly divided into 5 groups:normal control group,model group,Simvastatin group,low-dose Xuanyun-Ⅲ group,and high-dose Xuanyun-Ⅲ group.Except the normal control group,the rats of the other groups were given an intraperitoneal injection dose of vitamin D 3(300 000 IU/kg)at the beginning of feeding,together with high-fat feedstuff to set up rat models with cerebral arteriosclerosis.Gavage administration was conducted after seven weeks,while the normal control group and the model group were given distilled water gavage.After eight weeks,all rats were sacrificed,and the serum lipid and the biochemical criteria such as superoxide dismutase(SOD),the content of Malondialdehyde(MAD)were detected in the brain tissues.Pathological examinations of cerebral vascular were performed as well.Results Xuanyun-Ⅲ can reduce serum lipid and the content of Malondialdehyde(MAD),and improve the SOD activity(P <0.05).Cerebral endarterium endothelial cells of the rats in the model group presented universal degeneration,necrosis,ablation,and atheromatous plaque formed.The above indexes were all improved after the treatment of Xuanyun-Ⅲ.Conclusion Xuanyun-Ⅲ can improve the serum lipid and oxidizability of the rats with cerebral arteriosclerosis,alleviate the pathological lesion of brain blood vessel,which shows that Xuanyun-Ⅲ can prevent and treat cerebral arteriosclerosis.
What problem does this paper attempt to address?